These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 34937929)

  • 1. Cross-reactive adaptive immunity against coronaviruses in young children.
    Nat Immunol; 2022 Jan; 23(1):11-12. PubMed ID: 34937929
    [No Abstract]   [Full Text] [Related]  

  • 2. Is preexisting immunity to seasonal coronaviruses limited to cross-reactivity with SARS-CoV-2? A seroprevalence cross-sectional study in north-eastern France.
    Zedan HT; Nasrallah GK
    EBioMedicine; 2021 Sep; 71():103580. PubMed ID: 34525435
    [No Abstract]   [Full Text] [Related]  

  • 3. Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection.
    Dowell AC; Butler MS; Jinks E; Tut G; Lancaster T; Sylla P; Begum J; Bruton R; Pearce H; Verma K; Logan N; Tyson G; Spalkova E; Margielewska-Davies S; Taylor GS; Syrimi E; Baawuah F; Beckmann J; Okike IO; Ahmad S; Garstang J; Brent AJ; Brent B; Ireland G; Aiano F; Amin-Chowdhury Z; Jones S; Borrow R; Linley E; Wright J; Azad R; Waiblinger D; Davis C; Thomson EC; Palmarini M; Willett BJ; Barclay WS; Poh J; Amirthalingam G; Brown KE; Ramsay ME; Zuo J; Moss P; Ladhani S
    Nat Immunol; 2022 Jan; 23(1):40-49. PubMed ID: 34937928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tackling COVID19 by Exploiting Pre-existing Cross-Reacting Spike-Specific Immunity.
    Zeng Q; Huang G; Li YZ; Xu Y
    Mol Ther; 2020 Nov; 28(11):2314-2315. PubMed ID: 33038327
    [No Abstract]   [Full Text] [Related]  

  • 5. Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63.
    Saletti G; Gerlach T; Jansen JM; Molle A; Elbahesh H; Ludlow M; Li W; Bosch BJ; Osterhaus ADME; Rimmelzwaan GF
    Sci Rep; 2020 Dec; 10(1):21447. PubMed ID: 33293664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How kids' immune systems can evade COVID.
    Nogrady B
    Nature; 2020 Dec; 588(7838):382. PubMed ID: 33303982
    [No Abstract]   [Full Text] [Related]  

  • 7. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray.
    Camerini D; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Shandling A; Huynh V; Teng AA; Hermanson G; Pablo JV; Stumpf MM; Lester SN; Harcourt J; Tamin A; Rasheed M; Thornburg NJ; Satheshkumar PS; Liang X; Kennedy RB; Yee A; Townsend M; Campo JJ
    Microbiol Spectr; 2021 Oct; 9(2):e0141621. PubMed ID: 34704808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of SARS-CoV-2 Immunity in Convalescent Children and Adolescents.
    Tsang HW; Chua GT; To KKW; Wong JSC; Tu W; Kwok JSY; Wong WHS; Wang X; Zhang Y; Rosa Duque JS; Chan GCF; Chu WK; Pang CP; Tam PKH; Lau YL; Wong ICK; Leung WH; Yuen KY; Kwan MYW; Ip P
    Front Immunol; 2021; 12():797919. PubMed ID: 34975908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France.
    Woudenberg T; Pelleau S; Anna F; Attia M; Donnadieu F; Gravet A; Lohmann C; Seraphin H; Guiheneuf R; Delamare C; Stefic K; Marlet J; Brochot E; Castelain S; Augereau O; Sibilia J; Dubos F; Meddour D; Guen CG; Coste-Burel M; Imbert-Marcille BM; Chauvire-Drouard A; Schweitzer C; Gatin A; Lomazzi S; Joulié A; Haas H; Cantais A; Bertholon F; Chinazzo-Vigouroux MF; Abdallah MS; Arowas L; Charneau P; Hoen B; Demeret C; Werf SV; Fontanet A; White M
    EBioMedicine; 2021 Aug; 70():103495. PubMed ID: 34304047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commercial immunoglobulin products contain cross-reactive but not neutralizing antibodies against SARS-CoV-2.
    Ahn TS; Han B; Krogstad P; Bun C; Kohn LA; Garcia-Lloret MI; Damoiseaux R; Butte MJ
    J Allergy Clin Immunol; 2021 Mar; 147(3):876-877. PubMed ID: 33358557
    [No Abstract]   [Full Text] [Related]  

  • 11. Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study.
    Guo L; Wang Y; Kang L; Hu Y; Wang L; Zhong J; Chen H; Ren L; Gu X; Wang G; Wang C; Dong X; Wu C; Han L; Wang Y; Fan G; Zou X; Li H; Xu J; Jin Q; Cao B; Wang J
    Emerg Microbes Infect; 2021 Dec; 10(1):664-676. PubMed ID: 33734013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2.
    Galipeau Y; Siragam V; Laroche G; Marion E; Greig M; McGuinty M; Booth RA; Durocher Y; Cuperlovic-Culf M; Bennett SAL; Crawley AM; Giguère PM; Cooper C; Langlois MA
    EBioMedicine; 2021 Dec; 74():103700. PubMed ID: 34861490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts.
    Kundu R; Narean JS; Wang L; Fenn J; Pillay T; Fernandez ND; Conibear E; Koycheva A; Davies M; Tolosa-Wright M; Hakki S; Varro R; McDermott E; Hammett S; Cutajar J; Thwaites RS; Parker E; Rosadas C; McClure M; Tedder R; Taylor GP; Dunning J; Lalvani A
    Nat Commun; 2022 Jan; 13(1):80. PubMed ID: 35013199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systems serology detects functionally distinct coronavirus antibody features in children and elderly.
    Selva KJ; van de Sandt CE; Lemke MM; Lee CY; Shoffner SK; Chua BY; Davis SK; Nguyen THO; Rowntree LC; Hensen L; Koutsakos M; Wong CY; Mordant F; Jackson DC; Flanagan KL; Crowe J; Tosif S; Neeland MR; Sutton P; Licciardi PV; Crawford NW; Cheng AC; Doolan DL; Amanat F; Krammer F; Chappell K; Modhiran N; Watterson D; Young P; Lee WS; Wines BD; Mark Hogarth P; Esterbauer R; Kelly HG; Tan HX; Juno JA; Wheatley AK; Kent SJ; Arnold KB; Kedzierska K; Chung AW
    Nat Commun; 2021 Apr; 12(1):2037. PubMed ID: 33795692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection.
    Rosati M; Terpos E; Ntanasis-Stathopoulos I; Agarwal M; Bear J; Burns R; Hu X; Korompoki E; Donohue D; Venzon DJ; Dimopoulos MA; Pavlakis GN; Felber BK
    Front Immunol; 2021; 12():793953. PubMed ID: 34899762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological imprinting of the antibody response in COVID-19 patients.
    Aydillo T; Rombauts A; Stadlbauer D; Aslam S; Abelenda-Alonso G; Escalera A; Amanat F; Jiang K; Krammer F; Carratala J; García-Sastre A
    Nat Commun; 2021 Jun; 12(1):3781. PubMed ID: 34145263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Previous viral symptoms and individual mothers influenced the leveled duration of human milk antibodies cross-reactive to S1 and S2 subunits from SARS-CoV-2, HCoV-229E, and HCoV-OC43.
    Demers-Mathieu V; DaPra C; Mathijssen GB; Medo E
    J Perinatol; 2021 May; 41(5):952-960. PubMed ID: 33649442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers.
    Jackson-Thompson BM; Goguet E; Laing ED; Olsen CH; Pollett S; Hollis-Perry KM; Maiolatesi SE; Illinik L; Ramsey KF; Reyes AE; Alcorta Y; Wong MA; Davies J; Ortega O; Parmelee E; Lindrose AR; Moser M; Graydon E; Letizia AG; Duplessis CA; Ganesan A; Pratt KP; Malloy AM; Scott DW; Anderson SK; Snow AL; Dalgard CL; Powers JH; Tribble D; Burgess TH; Broder CC; Mitre E
    BMC Infect Dis; 2021 Jun; 21(1):544. PubMed ID: 34107889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Infection Severity Is Linked to Superior Humoral Immunity against the Spike.
    Guthmiller JJ; Stovicek O; Wang J; Changrob S; Li L; Halfmann P; Zheng NY; Utset H; Stamper CT; Dugan HL; Miller WD; Huang M; Dai YN; Nelson CA; Hall PD; Jansen M; Shanmugarajah K; Donington JS; Krammer F; Fremont DH; Joachimiak A; Kawaoka Y; Tesic V; Madariaga ML; Wilson PC
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection.
    Yatim N; Boussier J; Tetu P; Smith N; Bruel T; Charbit B; Barnabei L; Corneau A; Da Meda L; Allayous C; Baroudjian B; Jebali M; Herms F; Grzelak L; Staropoli I; Calmettes V; Hadjadj J; Peyrony O; Cassius C; LeGoff J; Kramkimel N; Aractingi S; Fontes M; Blanc C; Rieux-Laucat F; Schwartz O; Terrier B; Duffy D; Lebbé C
    Sci Adv; 2021 Aug; 7(34):. PubMed ID: 34407944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.